Surgery Partners is a leading provider of surgical services, focused on delivering high-quality, cost-effective healthcare solutions
The company operates a network of ambulatory surgery centers and surgical hospitals, offering a diverse range of surgical procedures across various specialties. By collaborating with physicians and healthcare professionals, Surgery Partners aims to enhance patient experiences and outcomes while ensuring efficient operational processes. Their commitment to quality care, innovation, and patient-centered services positions them as a key player in the healthcare industry, addressing the growing demand for outpatient surgical services.
Healthcare company Surgery Partners (NASDAQSGRY) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 17.5% year on year to $864.4 million. The company expects the full year’s revenue to be around $3.38 billion, close to analysts’ estimates. Its non-GAAP profit of $0.44 per share was 16.7% above analysts’ consensus estimates.
Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners experiencing significant growth due to strategic developments.
Concentra, a subsidiary of select medical, recently priced its IPO at $23.50 per share. Concentra offers occupational health services with 547 centers in 41 states.
U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQSGRY) fell sharply during Monday’s session following weak quarterly sales.
